
In Vitro Diagnostic (IVD) Trends and Market Update, 2025 [published twice a year]
Description
Kalorama Information’s In Vitro Diagnostic (IVD) Trends and Market Update, 2025 provides the latest insights into the dynamic IVD market amid ongoing economic and global uncertainties. Published twice a year—first in April 2025 and again in Q4 2025, following the release of Kalorama’s annual 1,600-page study, The Worldwide Market for In Vitro Diagnostics (IVD), 18th Edition—this report serves both as a standalone resource and a companion to Kalorama’s annual flagship IVD analysis.
In 2024, the IVD market continued to expand, with most segments experiencing growth, despite the decline in COVID-19 testing revenues. AI-driven innovations, regulatory shifts, and changes in global healthcare spending are shaping the competitive landscape, reinforcing the resilience of the IVD sector.
Key growth areas attracting industry attention and that are anticipated to play a significant role in the future of IVD include:
In 2024, the IVD market continued to expand, with most segments experiencing growth, despite the decline in COVID-19 testing revenues. AI-driven innovations, regulatory shifts, and changes in global healthcare spending are shaping the competitive landscape, reinforcing the resilience of the IVD sector.
Key growth areas attracting industry attention and that are anticipated to play a significant role in the future of IVD include:
- Point-of-care diabetes testing
- Companion diagnostics technologies
- Immunochemistry
- Mass spectrometry
- Nucleic acid assays
- HPV molecular diagnostics
- New product developments shaping IVD innovation
- Competitive landscape insights and activities of key players
- Emerging opportunities and strategic growth areas
Table of Contents
50 Pages
- IVD Market Demand and Growth
- Effect of COVID-19 on Market Segments
- Selected New - Q4 2024 and Q1 2025: Core IVD Product Launches, Developments, and Trends
- Selected Competitive Leader Updates
- Q4 2024, Q1 2025 M&A Activity
- Abbott Laboratories
- Becton Dickinson and Co
- bioMérieux SA
- Danaher Corporation
- Dexcom, Inc
- Exact Sciences
- QuidelOrtho Corporation
- Roche Diagnostic
- Siemens Healthineers
- Sysmex Corporation
- Thermo Fisher Scientific
- Staffing Shortages
- LDT Update
- IVDR Compliance Deadline Approaches
- Telemedicine
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.